Scientific Support for NQR Explosive Detection Development

2006 ◽  
Author(s):  
B. H. Suits
Keyword(s):  
Explosive Detection ◽  
Scientific Support

Cannabis-associated arteritis

VASA ◽  
2010 ◽  
Vol 39 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Grotenhermen
Keyword(s):  
Systematic Review ◽  
Case Reports ◽  
Case Series ◽  
Cardiovascular Effects ◽  
Causative Factor ◽  
Cannabis Use ◽  
Thromboangiitis Obliterans ◽  
Pathological Features ◽  
Scientific Support ◽  
Clinical And Pathological Features

Background: To investigate the hypothesis that cases of arteritis similar to thromboangiitis obliterans (TAO) and associated with the use of cannabis were caused by cannabis or THC (dronabinol), or that cannabis use is a co-factor of TAO. Patients and methods: A systematic review on case reports and the literature on so-called cannabis arteritis, TAO, and cardiovascular effects of cannabinoids was conducted. Results: Fifteen reports with 57 cases of an arteritis associated with the use of cannabis and two additional case series of TAO, in which some patients also used cannabis, were identified. Clinical and pathological features of cannabis-associated arteritis do not differ from TAO and the major risk factor of TAO, tobacco use, was present in most, if not in all of these cases. The proposed pathophysiological mechanisms for the development of an arteritis by cannabis use are not substantiated. Conclusions: The hypothesis of cannabis being a causative factor or co-factor of TAO or an arteritis similar to TAO is not supported by the available evidence. The use of the term “cannabis arteritis” should be avoided until or unless more convincing scientific support is forthcoming.

SCIENTIFIC SUPPORT OF THE POPULATION CENSUS

2018 ◽  
Vol 06 ◽  
pp. 35-42
Author(s):  
E.M. Libanova ◽  
◽  
I.E. Verner ◽  
Keyword(s):  
Population Census ◽  
Scientific Support

SCIENTIFIC SUPPORT OF THE STATE POLICY FUNDAMENTALS IN THE FIELD OF INDUSTRIAL SAFETY

2018 ◽  
pp. 7-14
Author(s):  
A.L. Rybas ◽  
◽  
N.A. Makhutov ◽  
M.M. Gadenin ◽  
A.S. Pecherkin ◽  
...  
Keyword(s):  
State Policy ◽  
The State ◽  
Industrial Safety ◽  
Scientific Support

Scientific Support for Industrial Safety is Thirty Years

2020 ◽  
pp. 7-16
Author(s):  
V.I. Sidorov ◽  
◽  
A.S. Pecherkin ◽  
E.V. Klovach ◽  
I.A. Kruchinina ◽  
...  
Keyword(s):  
Industrial Safety ◽  
Scientific Support

The main directions of scientific support for the implementation of the system of organic farming in Ukraine

2016 ◽  
Vol 1 (90) ◽  
pp. 22-24
Author(s):  
V.F. Kaminskyi ◽  
S.G. Korsun
Keyword(s):  
Land Use ◽  
Organic Farming ◽  
Crop Production ◽  
Land Ownership ◽  
Scientific Support ◽  
Speed Up ◽  
Organic Crop Production ◽  
Advanced Production ◽  
And Training ◽  
Organizational Issue

The aim of this work was to study the basic directions of scientific support introduction of organic farming in Ukraine. The study used methods of comparison, synthesis, analysis, induction and deduction. The article indicated on the main areas that need special attention from researchers and suggests one possible mechanism to remove the remaining obstacles to organizational issue introduction of scientific developments in the production of organic and training areas. This can speed up the creation of new and manage existing land ownership and land use organic farming with the introduction of advanced production technology of organic crop production.

Medical Liability for Off Label Use of Drugs in Romania

2018 ◽  
Vol 69 (3) ◽  
pp. 755-757
Author(s):  
Ionut Vida Simiti
Keyword(s):  
Side Effects ◽  
Medical Devices ◽  
Medical Liability ◽  
Criminal Offence ◽  
Off Label Use ◽  
National Agency ◽  
Off Label ◽  
Scientific Support ◽  
The Common ◽  
Label Use

Breaking the limits of the risks for the human body, health or even the life of the patient, as assumed by the pharmaceutical producers, by using a drug off label, for its side effects, in another purpose or even against the purpose for which the drug was authorized by the National Agency of Medicine and Medical Devices, is not in itself illegal if the off label use has the common consent of both the doctor and the patient for a treatment and only for a treatment which, although a spread procedure, has little or no scientific support. But if the patient is subjected to unreasonable risks, endangering his body, health or life beyond the possible benefits of the treatment, without being informed about the lack of scientific support, the doctor is liable not only for malpractice (civil medical liability) but also for a criminal offence.

Sign in / Sign up

Export Citation Format

Share Document